| Literature DB >> 35845612 |
Aijia Zhang1, Zilong Liu1, Man Liang1.
Abstract
Substance abuse has become a global problem due to drug-induced addiction and neurotoxicity, which causes a huge physical, social, and financial burden. Various kinds of drugs can hijack the users'/abusers' behavior and associated neurocircuitry. To summarize recent scientific advances on drug abuse, we reviewed relevant publications to analyze research progress and such trends through bibliometric ways. Based on retrieval strategies, a total of 681 scientific records published from 1997 to 2021 were screened and included in the Web of Science (WoS) database. Further scientometric analysis revealed that annual publication output increased across this period, with the United States of America (USA) contributing a significant number of reasons. Research has focused on neurotransmitter, oxidative stress, mitochondrial system injury, and other neurotoxic mechanisms. Neuroimmune, neurotoxic targets, and new psychoactive substances have been hot topics in recent years, which deserve continued research in the future. Specific research on molecular mechanisms has progressed across this period, with an emphasis on the root cause of toxicity and molecular targets for therapy. Moreover, collaborations of international multi-disciplinary research teams have been efficient and need to be encouraged for addiction research and the development of appropriate therapeutic processes.Entities:
Keywords: molecular mechanism; neurotoxicity; scientometric analysis; substance abuse; visualization
Year: 2022 PMID: 35845612 PMCID: PMC9283979 DOI: 10.3389/fnmol.2022.885701
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 6.261
FIGURE 1The flowchart of methodology.
FIGURE 2Annual number and accumulated number of articles on neurotoxicity of substance abuse, and number of publications on molecular mechanisms from 1997 to 2021.
The top 10 productive countries and institutions.
| Country or region | Articles (%) | Citations | H-index | Citations per article | Top country institution | Top institution articles (%) |
| United States | 346 (50.81%) | 15023 | 61 | 43.42 | National Institutes of Health Nih United States | 52 (15.03%) |
| Peoples R China | 63 (9.25%) | 861 | 18 | 13.67 | Southern Medical University China | 9 (14.29%) |
| Spain | 54 (7.93%) | 1436 | 24 | 27.09 | University of Barcelona | 16 (29.63%) |
| Japan | 33 (4.85%) | 1062 | 16 | 32.18 | Chiba University | 5 (15.15%) |
| Germany | 30 (4.41%) | 1355 | 20 | 45.17 | Humboldt University of Berlin | 9 (30.00%) |
| Portugal | 30 (4.41%) | 984 | 18 | 32.80 | Universidade Do Porto | 27 (90.00%) |
| Italy | 28 (4.11%) | 759 | 14 | 27.11 | University of Cagliari | 7 (25.00%) |
| Iran | 24 (3.52%) | 173 | 8 | 7.21 | Shahid Beheshti University Medical Sciences | 8 (33.33%) |
| England | 18 (2.64%) | 698 | 13 | 38.78 | University of London | 4 (22.22%) |
| South Korea | 18 (2.64%) | 353 | 8 | 19.61 | Kangwon National University | 7 (38.89%) |
FIGURE 3Cooperation between contributed countries.
The characteristics of highly cited articles.
| Rank | Total citations | Article title | Journal | Published year | Country | IF 2020 | IF 5- years | SJR 2020 |
| 1 | 688 | Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers | American Journal of Psychiatry | 2001 | United States | 18.112 | 17.825 | 5.477 |
| 2 | 459 | Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [C-11]WIN-35,428 | Journal of Neuroscience | 1998 | United States | 6.167 | 6.993 | 3.483 |
| 3 | 437 | Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence | Journal of Neuroscience | 2001 | United States | 6.167 | 6.993 | 3.483 |
| 4 | 423 | Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin | Nature Medicine | 1998 | England | 53.440 | 49.248 | 19.536 |
| 5 | 277 | Memory impairment in abstinent MDMA (”Ecstasy”) users | Neurology | 1998 | United States | 9.910 | 10.664 | 2.910 |
| 6 | 275 | Evidence for long-term neurotoxicity associated with methamphetamine abuse–A H-1 MRS study | Neurology | 2000 | United States | 9.910 | 10.664 | 2.910 |
| 7 | 275 | Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat | Journal of Neuroscience | 1998 | United States | 6.167 | 6.993 | 3.483 |
| 8 | 249 | Sex differences in striatal dopamine release in healthy adults | Biological Psychiatry | 2006 | United States | 13.382 | 14.103 | 5.335 |
| 9 | 245 | Methamphetamine causes microglial activation in the brains of human abusers | Journal of Neuroscience | 2008 | United States | 6.167 | 6.993 | 3.483 |
| 10 | 210 | Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism | Journal of Neuroscience | 2002 | United States | 6.167 | 6.993 | 3.483 |
The 10 most active journals that published articles on substance abuse and its neurotoxicity research.
| Journal | Published numbers (%) | IF 2020 | SJR 2020 | JCR quartile | Categories |
| Neurotoxicity Research | 26 (3.82%) | 3.911 | 0.923 | Q2 | Neuroscience; pharmacology, toxicology and pharmaceutics |
| Neuroscience | 25 (3.67%) | 3.590 | 1.297 | Q3 | Neuroscience |
| Psychopharmacology | 24 (3.52%) | 4.530 | 1.378 | Q2 | Pharmacology; toxicology and pharmaceutics |
| Brain Research | 20 (2.94%) | 3.252 | 1.037 | Q3 | Biochemistry, genetics and molecular biology; medicine; neuroscience |
| Neuroscience Letters | 19 (2.79%) | 3.046 | 0.944 | Q3 | Neuroscience |
| Neuropharmacology | 18 (2.64%) | 5.251 | 1.760 | Q2 | Neuroscience; pharmacology, toxicology and pharmaceutics |
| Neuropsychopharmacology | 18 (2.64%) | 7.855 | 2.704 | Q1 | Medicine; pharmacology, toxicology and pharmaceutics |
| Neurotoxicology | 16 (2.35%) | 4.294 | 1.060 | Q2 | Neuroscience; pharmacology, toxicology and pharmaceutics |
| Journal of Neurochemistry | 16 (2.35%) | 5.372 | 1.750 | Q2 | Biochemistry, genetics and molecular biology; neuroscience |
| Pharmacology Biochemistry and Behavior | 15 (2.20%) | 3.533 | 1.184 | Q2 | Biochemistry, genetics and molecular biology; neuroscience; pharmacology, toxicology and pharmaceutics |
FIGURE 4Network of keywords co-occurrence. The circle size and the link illustrated the frequency and relevance of keywords, respectively.
FIGURE 5Co-cited references timeline map of neurotoxicity of substance abuse. Nodes represent referenced documents. The size of nodes represents the frequencies of cited references, and the location reflects the present time. Years are arranged horizontally at the top. The clusters are performed based on the themes of co-cited references and the label of each cluster is shown at the end of the timeline.
FIGURE 6Top 24 keywords with the strongest citation bursts. Each blue or red short line represents a year, and a red line stands for a burst detected year.